@article{7178510a5871426d8ffac2c9f02f4547,
title = "Alzheimer's disease: The specter of fragmented policy and financing",
author = "Alan Lyles",
note = "Funding Information: Recognizing the disproportionately low level of public funding for research on AD compared with other highly prevalent conditions, Senator Barbara A. Mikulski (D-Md), Chair of the Senate Subcommittee on Retirement and Aging, introduced S898 (Alzheimer{\textquoteright}s Breakthrough Act of 2007) to increase the National Institutes of Health{\textquoteright}s commitment to funding for research into the prevention and cure of AD.4 The bill has 28 cosponsors, markup has been completed, and it is on the Senate legislative calendar under General Orders No. 330. Related legislation (H.R.1560) has been introduced in the House of Representatives by Representative Edward Markey (D-Ma), with 56 cosponsors.5 Funding Information: 6. Statement by Elias A. Zerhouni, M.D., Director, National Institutes of Health, Department of Health and Human Services, on NIH Research on Alzheimer{\textquoteright}s Disease and Other Cognitive Disorders before Committee on Health, Education, Labor, and Pensions Subcommittee on Retirement and Aging, United States Senate, Tuesday, July 17, 2007. http://www.hhs.gov/asl/testify/ 2007/07/t20070717c.html. Accessed January 15, 2008. Copyright: Copyright 2011 Elsevier B.V., All rights reserved.",
year = "2008",
month = jan,
doi = "10.1016/j.clinthera.2008.01.021",
language = "English (US)",
volume = "30",
pages = "192--194",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "1",
}